Trial Profile
The effect of statin [HMG-CoA reductase inhibitors] therapy (atorvastatin) on the progression of calcific valvular aortic stenosis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2017
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Aortic valve stenosis
- Focus Therapeutic Use
- 25 Jul 2017 Status changed from active, no longer recruiting to discontinued.
- 29 Jan 2008 New trial record.